Sodium cation

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Sodium cation
Accession Number
DB14516
Type
Small Molecule
Groups
Experimental
Description
Not Available
Structure
Thumb
Synonyms
  • Sodium (ion)
  • Sodium ion
  • sodium(1+)
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
NinePercentSodium cation (90 g/1000g)Injection, solutionIntravenousUS Specialty Formulations LLC2014-12-01Not applicableUs
Categories
UNII
LYR4M0NH37
CAS number
17341-25-2
Weight
Average: 22.9898
Monoisotopic: 22.989769675
Chemical Formula
Na
InChI Key
FKNQFGJONOIPTF-UHFFFAOYSA-N
InChI
InChI=1S/Na/q+1
IUPAC Name
sodium(1+) ion
SMILES
[Na+]

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteraction
AcetazolamideThe risk or severity of adverse effects can be increased when Acetazolamide is combined with Sodium cation.
AgmatineThe therapeutic efficacy of Sodium cation can be decreased when used in combination with Agmatine.
AlfentanilThe therapeutic efficacy of Sodium cation can be decreased when used in combination with Alfentanil.
AloglutamolThe therapeutic efficacy of Sodium cation can be decreased when used in combination with Aloglutamol.
AlphacetylmethadolThe therapeutic efficacy of Sodium cation can be decreased when used in combination with Alphacetylmethadol.
AlphaprodineThe therapeutic efficacy of Sodium cation can be decreased when used in combination with Alphaprodine.
Aluminum sulfateThe risk or severity of adverse effects can be increased when Sodium cation is combined with Aluminum sulfate.
AmilorideThe risk or severity of adverse effects can be increased when Amiloride is combined with Sodium cation.
AmiodaroneThe therapeutic efficacy of Sodium cation can be decreased when used in combination with Amiodarone.
AmlodipineThe therapeutic efficacy of Sodium cation can be decreased when used in combination with Amlodipine.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

References

General References
Not Available
External Links
Human Metabolome Database
HMDB0000588
KEGG Compound
C01330
ChemSpider
899
ChEBI
29101
HET
NA
PDB Entries
131d / 191d / 192d / 193l / 194l / 1a2c / 1a3d / 1a46 / 1a4w / 1a50
show 8284 more

Clinical Trials

Clinical Trials
Not Available

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
Injection, solutionIntravenous90 g/1000g
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP-0.77ChemAxon
pKa (Strongest Acidic)3.09ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count0ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area0 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity0 m3·mol-1ChemAxon
Polarizability1.78 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-00di-9000000000-25bf08b0ab99f8116a31
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-00di-9000000000-25bf08b0ab99f8116a31
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-00di-9000000000-25bf08b0ab99f8116a31
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-00di-9000000000-fba837e9c7559de06780
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-00di-9000000000-fba837e9c7559de06780
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-00di-9000000000-fba837e9c7559de06780

Taxonomy

Classification
Not classified

Drug created on July 12, 2018 10:35 / Updated on May 01, 2019 12:00